Certain naphthalenyl imidazo compounds and their pharmaceutical use |
| AND PREFERRED EMBODIMENT The Formulae I and Ia are recognized as being tautomeric structures of ... |
|
Method of treating patients suffering from chronic pain or chronic cough |
| OF THE INVENTION The present invention relates to methods of treating a patient in chronic pain or ... |
|
Cerebral vasodilating 20,21-dinoreburnamenine derivatives |
| OF THE INVENTION Within the compounds of formula I, the hydroxyl and the hydrogen in the 14-... |
|
Piperazinyl-imidazo[1,2-a]pyrazines |
| OF THE INVENTION The novel and pharmaceutically valuable compound of this invention has the ... |
|
6-Halo-5-cyclohexylindan-1-carbohydroxamic acid |
| We claim: 1. A compound of the formula ##STR19## wherein X represents halogen. 2. The compound as ... |
|
Phototherapy using methylene blue |
| OF THE INVENTION The thiazine dye methylene blue plus light has been shown to hydroxylate both ... |
|
1-alkyl-2-aminotetralin derivatives |
| We claim: 1. A compound of the formula ##STR32## wherein R.sup.3 the NR.sup.1 R.sup.2 group are in ... |
|
|
Metallo-substituted naphthalene
| Details |
|
Inventors: Rapoport, Henry; Snyder, Clinton D.;
Assignee: The Regents of the University of California (Berkeley, CA)
Primary Examiner: Helfin; Bernard
Assistant Examiner:
Attorney, Agent or Firm: Bernard & Brown
3-Prenyl-substituted menaquinones are made by reacting a 3-metallo-2-alkyl-1,4-di(alkoxy or aralkoxy) naphthalene with a prenyl halide, and then oxidizing the resulting 3-prenyl-2-alkyl-1,4-di(alkoxy or aralkoxy) naphthalene to prepare the corresponding 3-prenyl-substituted menaquinone. The metallo substituent at the 3-position may be Li, Li/Cu, Cu or MgBr. The oxidation is advantageously conducted by the use of argentic oxide. |
|
DETAILED DESCRIPTION It is claimed: 1. Compounds of the formula ##STR4## wherein R is lower alkyl and R. sub. 1 and R. sub. 2 are lower alkyl, or aralkyl of 7 to about 12 carbon atoms, and M is MgBr. 2. The compounds of claim 1 wherein R is methyl. 3. The compounds of claim 2 wherein R. sub. 1 and R. sub. 2 are methyl.
Description:
This invention relates to a method of synthesizing menaquinones, and particularly 3-prenyl-2-alkyl menaquinones. The invention includes the preparation of 3-metallo-2-alkyl-1,4-di(alkoxy or aralkoxy) naphthalenes, and these intermediates have as the 3-metallo substituent lithium, lithium/copper, copper or magnesium bromide. The invention provides as novel compounds the intermediates in which the 3-metallo substituent is lithium/copper, copper or magnesium bromide. According to the invention the 3-metallo intermediates can be reacted with a prenyl halide to prepare the corresponding 3-prenyl-2-alkyl-1,4-di(alkoxy or aralkoxy) naphthalenes, which can be oxidized to the corresponding 3-prenyl-2-alkyl menaquinones. It is a further aspect of the invention that the oxidation is advantageously conducted by the use of argentic oxide. The 3-prenyl-2-alkyl menaquinones prepared by this invention have the structural formula: ##STR1## wherein R is alkyl, for instance, lower alkyl, say of 1 to about 4 or 8 carbon atoms, preferably methyl, and wherein Z is --CH. sub. 2 CH. dbd. C(CH. sub. 3)CH. sub. 2 ]. sub. m, --CH. sub. 2 CH. sub. 2 CH(CH. sub. 3)CH. sub. 2 ]. sub. n or combinations thereof, and in which each of m and n, and their sum may be 0 to about 25 or more, and frequently, each of m and n and their sum are 0 or 1 to about 9 or 12. For convenience, these compounds are sometimes hereafter referred to as the MK Compounds or the MK-integer Compounds wherein the integer represents the value of m plus n plus 1. These compounds have heretofore been designated as being in the vitamin K series, see U. S. Pat. No. 2,348,037, and can be administered to red-blooded animals in the usual manner as vitamin K compounds to combat bleeding
|
|